| HOME >> BIOLOGY >> TECHNOLOGY |
ROCKVILLE, Md., May 14 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) Novavax today announced Chief Executive Officer Dr. Rahul Singhvi will present at ACUMENBioFin's 5th Annual Global Healthcare Conference at 5:05 am Eastern time (11:05 am CEST) on May 19 at the Meridien Beach Plaza Hotel in Monaco, the company announced today.
Dr. Singhvi will provide an overview of the company's strategy, research and development progress and its unique manufacturing solution. A link to an audio webcast of his presentation will be available at 5:05 am Eastern time (11:05 am CEST) on Monday, May 19 through the company's website, http://www.novavax.com. An archive of the presentation will be available one hour after the event on the Novavax website for 30 days.
ABOUT NOVAVAX
Novavax, Inc. is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP based, potent recombinant vaccines utilizing a new, efficient manufacturing solution. Additional information about Novavax is available at http://www.novavax.com and in the Company's various filings with the Securities and Exchange Commission.
'/>"/>
| SOURCE Novavax, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Novavax Reports First Quarter 2008 Financial Results
2. Novavax Announces Release Date of 2008 First Quarter Financial Results and Investor Conference Call
3. Novavax Opens Its First U.S. Vaccine Plant
4. Novavax CEO to Present at the World Vaccine Congress 2008
5. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
6. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
7. Novavax CEO to Present at BIO CEO & Investor Conference
8. Access Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
9. Interleukin Genetics to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
10. ViroPharma to Present at the Seventh Annual JMP Securities Research Conference
11. Nile Therapeutics to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |